Maciej Kujawski

city of hope

H指数:30

被引数:6,371

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Carcinoembryonic Antigen (CEA) as a Therapeutic Target in Medullary Thyroid Cancer (MTC)

癌胚抗原(CEA)作为髓样甲状腺癌(MTC)的治疗靶点

Cancers

IF4.4

2026-10-240

Combination Image-Guided and Antibody-Targeted a-Therapy Before Targeted Immunotherapy for Treatment of Solid Tumors

图像引导与抗体靶向α疗法相结合，在靶向免疫疗法之前用于治疗实体瘤

JOURNAL OF NUCLEAR MEDICINE

IF9.1

2025-10-010

PRE

Intestinal epithelial Ceacam1 deficiency prevents steroid-refractory acute gut graft-versus-host disease

肠道上皮细胞Ceacam1缺乏可预防对糖皮质激素治疗无效的急性肠道移植物抗宿主病

JCI INSIGHT

IF6.1

2025-09-090

PRE

Reengineered Anti-CD4 Cys-diabody Variants for 89Zr-immunoPET of CD4+ T Cells in Immunocompetent Mice

重工程抗CD4半胱氨酸二体变体用于免疫健全小鼠中CD4+ T细胞的89Zr-免疫PET成像

Molecular Imaging and Biology

IF2.5

2025-08-070

OAAI

Development and Potent Anti-Tumor Activity of a Fully Humanized Anti-TAG-72-IL-2 Fusion Protein for Therapy of Solid Tumors

一种完全人源化抗TAG-72-IL-2融合蛋白的开发及其对实体瘤的强效抗肿瘤活性研究

CANCERS

IF4.4

2025-04-260

Development of Anti-CEA CH2 Domain-Deleted Antibody (M5A△CH2) for the PET Imaging of Colorectal Cancer

MOLECULAR IMAGING AND BIOLOGY

IF2.5

2025-03-010

OAAI

Targeting CEA in metastatic triple negative breast cancer with image-guided radiation followed by Fab-mediated chimeric antigen receptor (CAR) T-cell therapy

FRONTIERS IN IMMUNOLOGY

IF5.9

2024-12-200

OAAI

Current investigation of carcinoembryonic antigen cell adhesion molecule (CEACAM) biology summary of the 32nd CEA symposium: 20-23 September 2024. Würzburg, Germany

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

IF3.6

2024-12-140

PRE

Ex-vivo CS1-OKT3 dual specific bivalent antibody-armed effector T cells mediate cellular immunity against multiple myeloma

SCIENTIFIC REPORTS

IF3.9

2023-11-270

OAAI

Generation of IL-2-Fc-antibody conjugates by click chemistry

BIOTECHNOLOGY JOURNAL

IF3.1

2023-06-205

Improved Tumor Responses with Sequential Targeted a-Particles Followed by Interleukin 2 Immunocytokine Therapies in Treatment of CEA-Positive Breast and Colon Tumors in CEA Transgenic Mice

JOURNAL OF NUCLEAR MEDICINE

IF9.1

2022-06-302

T-cell surface generation of dual bivalent, bispecific T-cell engaging, RNA duplex cross-linked antibodies (dbBiTERs) for re-directed tumor cell lysis

BIOTECHNOLOGY JOURNAL

IF3.1

2021-11-254

Tumor regression and immunity in combination therapy with anti-CEA chimeric antigen receptor T cells and anti-CEA-IL2 immunocytokine

抗CEA嵌合抗原受体T细胞和anti-CEA-IL2免疫细胞因子联合治疗的肿瘤消退和免疫

ONCOIMMUNOLOGY

IF6.3

2021-03-1837

OAAI

Hepatic CEACAM1 expression indicates donor liver quality and prevents early transplantation injury

JOURNAL OF CLINICAL INVESTIGATION

IF13.6

2020-04-2043

Potent immunomodulatory effects of an anti-CEA-IL-2 immunocytokine on tumor therapy and effects of stereotactic radiation

ONCOIMMUNOLOGY

IF6.3

2020-02-1418

OAAI

Generation of dual specific bivalent BiTEs (dbBIspecific T-cell engaging antibodies) for cellular immunotherapy

BMC CANCER

IF3.4

2019-09-0512

OAAI

Bacteroides fragilis polysaccharide A induces IL-10 secreting B and T cells that prevent viral encephalitis

NATURE COMMUNICATIONS

IF15.7

2019-05-14198

OAAI

Prototype Small-Animal PET-CT Imaging System for Image-Guided Radiation Therapy

IEEE ACCESS

IF3.6

2019-01-0111

OAAI

CTLA4 aptamer delivers STAT3 siRNA to tumor-associated and malignant T cells (vol 124, pg 2977, 2014)

JOURNAL OF CLINICAL INVESTIGATION

IF13.6

2015-06-0113

OAAI

CTLA4 aptamer delivers STAT3 siRNA to tumor-associated and malignant T cells

JOURNAL OF CLINICAL INVESTIGATION

IF13.6

2014-06-02127

Maciej Kujawski

个人简介

教育背景

工作经历

荣誉奖项

研究方向